Behavioural effects of antidepressants are dependent and independent on the integrity of the dentate gyrus

International Journal of Neuropsychopharmacology

Volumn 14, Issue 7, 2011, Pages 967-976

  Miyamoto, Daisuke ^a   Iijima, Minoru ^a   Yamamoto, Haruka ^a   Nomura, Hiroshi ^a   Matsuki, Norio ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Antidepressant; colchicine; dentate gyrus; forced swimming test; neurogenesis

Indexed keywords

ANTIDEPRESSANT AGENT; DESIPRAMINE; FLUOXETINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN DAMAGE; CONTROLLED STUDY; DENTATE GYRUS; DRUG EFFECT; FORCED SWIMMING TEST; IMMOBILIZATION; LATENT PERIOD; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS; COLCHICINE; DENTATE GYRUS; DESIPRAMINE; DRUG ADMINISTRATION SCHEDULE; EXCITATORY POSTSYNAPTIC POTENTIALS; FEEDING BEHAVIOR; FLUOXETINE; IMMOBILITY RESPONSE, TONIC; MALE; MAZE LEARNING; MICROINJECTIONS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 80052970501     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145710001276     Document Type: Article

References (42)

1. Adachi M, Barrot M, Autry AE, Theobald D, et al. (2008). Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy. Biological Psychiatry 63, 642-649. (Pubitemid 351329281)
2. Airan RD, Meltzer LA, Roy M, Gong Y, et al. (2007). High-speed imaging reveals neurophysiological links to behavior in an animal model of depression. Science 317, 819-823. (Pubitemid 47257922)
3. Bechtholt AJ, Valentino RJ, Lucki I (2008). Overlapping and distinct brain regions associated with the anxiolytic effects of chlordiazepoxide and chronic fluoxetine. Neuropsychopharmacology 33, 2117-2130. (Pubitemid 351992086)
4. Bessa JM, Ferreira D, Melo I, Marques F, et al. (2009). The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Molecular Psychiatry 14, 764-773, 739.
5. Campbell S, Marriott M, Nahmias C, MacQueen GM (2004). Lower hippocampal volume in patients suffering from depression: a meta-analysis. American Journal of Psychiatry 161, 598-607. (Pubitemid 38445502)
6. Conrad LC, Leonard CM, Pfaff DW (1974). Connections of the median and dorsal raphe nuclei in the rat: an autoradiographic and degeneration study. Journal of Comparative Neurology 156, 179-205.
7. David DJ, Samuels BA, Rainer Q, Wang JW, et al. (2009). Neurogenesis-dependent and-independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 62, 479-493.
8. DeCarolis NA, Eisch AJ (2010). Hippocampal neurogenesis as a target for the treatment of mental illness: a critical evaluation. Neuropharmacology 58, 884-893.
9. Eisch AJ, Cameron HA, Encinas JM, Meltzer LA, et al. (2008). Adult neurogenesis, mental health, and mental illness: hope or hype? Journal of Neuroscience 28, 11785-11791.
10. Goldschmidt RB, Steward O (1980). Preferential neurotoxicity of colchicine for granule cells of the dentate gyrus of the adult rat. Proceedings of the National Academy of Sciences USA 77, 3047-3051. (Pubitemid 10031728)
11. Goldschmidt RB, Steward O (1982). Neurotoxic effects of colchicine: differential susceptibility of CNS neuronal populations. Neuroscience 7, 695-714. (Pubitemid 12192049)
12. Gould NF, Holmes MK, Fantie BD, Luckenbaugh DA, et al. (2007). Performance on a virtual reality spatial memory navigation task in depressed patients. American Journal of Psychiatry 164, 516-519. (Pubitemid 46513167)
13. Hernandez-Rabaza V, Barcia JA, Llorens-Martin M, Trejo JL, et al. (2007). Spared place and object-place learning but limited spatial working memory capacity in rats with selective lesions of the dentate gyrus. Brain Research Bulletin 72, 315-323. (Pubitemid 46602755)
14. Hiemke C, Hartter S (2000). Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacology & Therapeutics 85, 11-28.
15. Holick KA, Lee DC, Hen R, Dulawa SC (2008). Behavioral effects of chronic fluoxetine in BALB/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor. Neuropsychopharmacology 33, 406-417. (Pubitemid 350243341)
16. Kohler C, Steinbusch H (1982). Identification of serotonin and non-serotonin-containing neurons of the mid-brain raphe projecting to the entorhinal area and the hippocampal formation. A combined immunohistochemical and fluorescent retrograde tracing study in the rat brain. Neuroscience 7, 951-975. (Pubitemid 12122247)
17. Krahl SE, Senanayake SS, Pekary AE, Sattin A (2004). Vagus nerve stimulation (VNS) is effective in a rat model of antidepressant action. Journal of Psychiatric Research 38, 237-240. (Pubitemid 38299160)
18. Kumakura K, Nomura H, Toyoda T, Hashikawa K, et al. (2010). Hyperactivity in novel environment with increased dopamine and impaired novelty preference in apoptosis signal-regulating kinase 1 (ASK1)-deficient mice. Neuroscience Research 66, 313-320.
19. MacQueen GM, Campbell S, McEwen BS, Macdonald K, et al. (2003). Course of illness, hippocampal function, and hippocampal volume in major depression. Proceedings of the National Academy of Sciences USA 100, 1387-1392. (Pubitemid 36184011)
20. Mayberg HS, Brannan SK, Tekell JL, Silva JA, et al. (2000). Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biological Psychiatry 48, 830-843.
21. Monje ML, Toda H, Palmer TD (2003). Inflammatory blockade restores adult hippocampal neurogenesis. Science 302, 1760-1765. (Pubitemid 37505739)
22. Moore RY, Halaris AE (1975). Hippocampal innervation by serotonin neurons of the midbrain raphe in the rat. Journal of Comparative Neurology 164, 171-183.
23. Nakao K, Ikegaya Y, Yamada MK, Nishiyama N, et al. (2002). Hippocampal long-term depression as an index of spatial working memory. European Journal of Neuroscience 16, 970-974. (Pubitemid 35463589)
24. Nakao K, Matsuyama K, Matsuki N, Ikegaya Y (2004). Amygdala stimulation modulates hippocampal synaptic plasticity. Proceedings of the National Academy of Sciences USA 101, 14270-14275. (Pubitemid 39305064)
25. Nibuya M, Morinobu S, Duman RS (1995). Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. Journal of Neuroscience 15, 7539-7547.
26. Petit-Demouliere B, Chenu F, Bourin M (2005). Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology (Berlin) 177, 245-255. (Pubitemid 40137284)
27. Porsolt RD, Le Pichon M, Jalfre M (1977). Depression: a new animal model sensitive to antidepressant treatments. Nature 266, 730-732. (Pubitemid 8073804)
28. Reif A, Fritzen S, Finger M, Strobel A, et al. (2006). Neural stem cell proliferation is decreased in schizophrenia, but not in depression. Molecular Psychiatry 11, 514-522.
29. Richardson-Jones JW, Craige CP, Guiard BP, Stephen A, et al. (2010). 5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants. Neuron 65, 40-52.
30. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, et al. (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. American Journal of Psychiatry 163, 1905-1917. (Pubitemid 44807782)
31. Russo-Neustadt A, Beard RC, Cotman CW (1999). Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression. Neuropsychopharmacology 21, 679-682. (Pubitemid 29486636)
32. Santarelli L, Saxe M, Gross C, Surget A, et al. (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301, 805-809. (Pubitemid 36962615)
33. Sapolsky RM (2004). Is impaired neurogenesis relevant to the affective symptoms of depression? Biological Psychiatry 56, 137-139. (Pubitemid 38969144)
34. Seubert P, Nakagawa Y, Ivy G, Vanderklish P, et al. (1989). Intrahippocampal colchicine injection results in spectrin proteolysis. Neuroscience 31, 195-202. (Pubitemid 19209709)
35. Shirayama Y, Chen AC, Nakagawa S, Russell DS, et al. (2002). Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. Journal of Neuroscience 22, 3251-3261. (Pubitemid 35379212)
36. Tandon P, McLamb RL, Novicki D, Shuey DL, et al. (1988). Fetal hippocampal cell suspensions ameliorate behavioral effects of intradentate colchicine in the rat. Brain Research 473, 241-248. (Pubitemid 19008236)
37. Vertes RP, Fortin WJ, Crane AM (1999). Projections of the median raphe nucleus in the rat. Journal of Comparative Neurology 407, 555-582. (Pubitemid 29196671)
38. Videbech P, Ravnkilde B (2004). Hippocampal volume and depression: a meta-analysis of MRI studies. American Journal of Psychiatry 161, 1957-1966. (Pubitemid 39441394)
39. Wang JW, David DJ, Monckton JE, Battaglia F, et al. (2008). Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells. Journal of Neuroscience 28, 1374-1384. (Pubitemid 351231535)
40. Wong ML, Licinio J (2001). Research and treatment approaches to depression. Nature Reviews Neuroscience 2, 343-351. (Pubitemid 33680576)
41. Xavier GF, Oliveira-Filho FJ, Santos AM (1999). Dentate gyrus-selective colchicine lesion and disruption of performance in spatial tasks: difficulties in 'place strategy' because of a lack of flexibility in the use of environmental cues? Hippocampus 9, 668-681. (Pubitemid 30018858)
42. Young EA, Haskett RF, Grunhaus L, Pande A, et al. (1994). Increased evening activation of the hypothalamic-pituitary-adrenal axis in depressed patients. Archives of General Psychiatry 51, 701-707. (Pubitemid 24281780)